Juniper Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Juniper Therapeutics - overview
Location
Singapore, -, Singapore
Primary Industry
Healthcare
About
Based in Singapore, Juniper Therapeutics is a healthcare company that provides radiology and imaging services. In February 2022, The Sylvan Group acquired a majority stake in Juniper Therapeutics. The company provides radiology and imaging services.
Current Investors
The Sylvan Group
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Juniper Therapeutics - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Juniper Therapeutics | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.